GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » FCF Yield %

Statera BioPharma (STU:7CB) FCF Yield % : -21.49 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Statera BioPharma's Trailing 12-Month Free Cash Flow is €0.00 Mil, and Market Cap is €0.05 Mil. Therefore, Statera BioPharma's FCF Yield % for today is -21.49%.

The historical rank and industry rank for Statera BioPharma's FCF Yield % or its related term are showing as below:

STU:7CB' s FCF Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -21.49


STU:7CB's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -14.53 vs STU:7CB: -21.49

Statera BioPharma's FCF Margin % for the quarter that ended in Sep. 2022 was 0.00%.


Statera BioPharma FCF Yield % Historical Data

The historical data trend for Statera BioPharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma FCF Yield % Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
FCF Yield %
- - -

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Statera BioPharma's FCF Yield %

For the Biotechnology subindustry, Statera BioPharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Statera BioPharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's FCF Yield % falls into.



Statera BioPharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Statera BioPharma's FCF Yield % for the fiscal year that ended in Dec. 2021 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-25.113 / 0
=N/A%

Statera BioPharma's annualized FCF Yield % for the quarter that ended in Sep. 2022 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.81 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Statera BioPharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Statera BioPharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Statera BioPharma (STU:7CB) Business Description

Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines